Compare $ADTX vs $MTNB | Chartloom

Compare

$ADTX vs $MTNB

Aditxt Inc · Matinas BioPharma Holdings Inc

ADTX

Aditxt Inc

MTNB

Matinas BioPharma Holdings Inc

Compare $ADTX vs $MTNB

Comparing Aditxt Inc and Matinas BioPharma Holdings Inc

ADTXAditxt Inc

MTNBMatinas BioPharma Holdings Inc

ADTXAditxt Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-74.0%

YTD performance

-100.0%

52W performance

-100.0%

FCF yield

-186.2%

MTNBMatinas BioPharma Holdings Inc

Market cap

$39M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-69.1%

52W performance

-89.8%

FCF yield

-16.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ADTX

MTNB

Detailed metrics comparison

ADTX

Aditxt Inc

MTNB

Matinas BioPharma Holdings Inc

Market Cap

ADTX$10M

MTNB$39M

Enterprise Value

ADTX$13M

MTNB$39M

Price

ADTX$0.01

MTNB$2.87

P/E Ratio

ADTXN/A

MTNBN/A

P/S Ratio

ADTX693.04x

MTNB0.60x

EV/Sales

ADTX903.97x

MTNB0.43x

EV/EBITDA

ADTX0.00x

MTNB0.00x

P/B Ratio

ADTX0.53x

MTNB1.44x

P/FCF Ratio

ADTXN/A

MTNBN/A

EV/FCF

ADTX-0.70x

MTNB-6.00x

PEG Ratio

ADTXN/A

MTNBN/A

Forward P/E (NTM)

ADTXN/A

MTNBN/A

Forward P/S (NTM)

ADTXN/A

MTNBN/A

Revenue (TTM)

ADTX$14K

MTNB$0

Revenue Growth (YoY)

ADTX-74.0%

MTNBN/A

Forward Rev Growth

ADTX0.0%

MTNB0.0%

Gross Margin (TTM)

ADTX20.1%

MTNB0.0%

Operating Margin (TTM)

ADTX0.0%

MTNB0.0%

EBITDA Margin (TTM)

ADTX-125503.5%

MTNB0.0%

Net Margin (TTM)

ADTX-370408.3%

MTNB0.0%

FCF Margin (TTM)

ADTX-129012.5%

MTNBN/A

Net Income (TTM)

ADTX$-53M

MTNB$-3M

FCF (TTM)

ADTX$-19M

MTNB$-6M

EPS (TTM)

ADTX-$2,640.53

MTNB$0.00

ROE (TTM)

ADTX-15077.0%

MTNB-13745.0%

ROA (TTM)

ADTX-27739.0%

MTNB-9202.0%

ROIC (TTM)

ADTX-11833.0%

MTNB-13717.0%

Cash

ADTX$269K

MTNB$761K

Debt

ADTX$3M

MTNB$6K

Net Cash/Debt

ADTX$-3M

MTNB$755K

Current Ratio (TTM)

ADTX0.06x

MTNB0.85x

Quick Ratio (TTM)

ADTX0.02x

MTNB0.60x

Debt/Equity (TTM)

ADTX0.33x

MTNB0.00x

Debt/Assets (TTM)

ADTX0.0%

MTNB0.0%

Interest Coverage (TTM)

ADTXN/A

MTNBN/A

Net Debt/EBITDA (TTM)

ADTX0.00x

MTNB0.00x

Beta

ADTX1.31

MTNB2.20

52W Performance

ADTX-100.0%

MTNB-89.8%

YTD Performance

ADTX-100.0%

MTNB-69.1%

% from 52W High

ADTX-100.0%

MTNB-90.1%

% from 52W Low

ADTXN/A

MTNB27.1%

Asset Turnover (TTM)

ADTX0.00x

MTNB0.09x

FCF Yield (TTM)

ADTX-186.2%

MTNB-16.3%

Earnings Yield (TTM)

ADTX-534.5%

MTNB-8.8%

Dividend Yield (TTM)

ADTXN/A

MTNBN/A

Rule of 40

ADTX-129,086.5

MTNB0.0

EV/GP/RG

ADTXN/A

MTNBN/A

Ticker research

View ADTX research View MTNB research

Metric	ADTX Aditxt Inc	MTNB Matinas BioPharma Holdings Inc
Market & Valuation
Market Cap	$10M	$39M
Enterprise Value	$13M	$39M
Price	$0.01	$2.87
P/E Ratio	N/A	N/A
P/S Ratio	693.04x	0.60x
EV/Sales	903.97x	0.43x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.53x	1.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.70x	-6.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$14K	$0
Revenue Growth (YoY)	-74.0%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	20.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-125503.5%	0.0%
Net Margin (TTM)	-370408.3%	0.0%
FCF Margin (TTM)	-129012.5%	N/A
Net Income (TTM)	$-53M	$-3M
FCF (TTM)	$-19M	$-6M
EPS (TTM)	-$2,640.53	$0.00
ROE (TTM)	-15077.0%	-13745.0%
ROA (TTM)	-27739.0%	-9202.0%
ROIC (TTM)	-11833.0%	-13717.0%
Financial Health
Cash	$269K	$761K
Debt	$3M	$6K
Net Cash/Debt	$-3M	$755K
Current Ratio (TTM)	0.06x	0.85x
Quick Ratio (TTM)	0.02x	0.60x
Debt/Equity (TTM)	0.33x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.31	2.20
52W Performance	-100.0%	-89.8%
YTD Performance	-100.0%	-69.1%
% from 52W High	-100.0%	-90.1%
% from 52W Low	N/A	27.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.09x
FCF Yield (TTM)	-186.2%	-16.3%
Earnings Yield (TTM)	-534.5%	-8.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-129,086.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ADTX research	View MTNB research

Valuation

P/S Ratio

MTNB

0.60x

ADTX

693.04x

EV/FCF

MTNB

-6.00x

ADTX

-0.70x

Growth & revenue

Revenue Growth TTM

ADTX

-74.0%

Forward Revenue Growth

ADTX

0.0%

MTNB

0.0%

Profitability & performance

Gross Margin

ADTX

20.1%

MTNB

0.0%

ROE

MTNB

-13745.0%

ADTX

-15077.0%

FCF Yield %

MTNB

-16.3%

ADTX

-186.2%

52-Week Performance

MTNB

-89.8%

ADTX

-100.0%

Detailed metrics comparison

ADTX

Aditxt Inc

MTNB

Matinas BioPharma Holdings Inc

Market Cap

ADTX$10M

MTNB$39M

Enterprise Value

ADTX$13M

MTNB$39M

Price

ADTX$0.01

MTNB$2.87

P/E Ratio

ADTXN/A

MTNBN/A

P/S Ratio

ADTX693.04x

MTNB0.60x

EV/Sales

ADTX903.97x

MTNB0.43x

EV/EBITDA

ADTX0.00x

MTNB0.00x

P/B Ratio

ADTX0.53x

MTNB1.44x

P/FCF Ratio

ADTXN/A

MTNBN/A

EV/FCF

ADTX-0.70x

MTNB-6.00x

PEG Ratio

ADTXN/A

MTNBN/A

Forward P/E (NTM)

ADTXN/A

MTNBN/A

Forward P/S (NTM)

ADTXN/A

MTNBN/A

Revenue (TTM)

ADTX$14K

MTNB$0

Revenue Growth (YoY)

ADTX-74.0%

MTNBN/A

Forward Rev Growth

ADTX0.0%

MTNB0.0%

Gross Margin (TTM)

ADTX20.1%

MTNB0.0%

Operating Margin (TTM)

ADTX0.0%

MTNB0.0%

EBITDA Margin (TTM)

ADTX-125503.5%

MTNB0.0%

Net Margin (TTM)

ADTX-370408.3%

MTNB0.0%

FCF Margin (TTM)

ADTX-129012.5%

MTNBN/A

Net Income (TTM)

ADTX$-53M

MTNB$-3M

FCF (TTM)

ADTX$-19M

MTNB$-6M

EPS (TTM)

ADTX-$2,640.53

MTNB$0.00

ROE (TTM)

ADTX-15077.0%

MTNB-13745.0%

ROA (TTM)

ADTX-27739.0%

MTNB-9202.0%

ROIC (TTM)

ADTX-11833.0%

MTNB-13717.0%

Cash

ADTX$269K

MTNB$761K

Debt

ADTX$3M

MTNB$6K

Net Cash/Debt

ADTX$-3M

MTNB$755K

Current Ratio (TTM)

ADTX0.06x

MTNB0.85x

Quick Ratio (TTM)

ADTX0.02x

MTNB0.60x

Debt/Equity (TTM)

ADTX0.33x

MTNB0.00x

Debt/Assets (TTM)

ADTX0.0%

MTNB0.0%

Interest Coverage (TTM)

ADTXN/A

MTNBN/A

Net Debt/EBITDA (TTM)

ADTX0.00x

MTNB0.00x

Beta

ADTX1.31

MTNB2.20

52W Performance

ADTX-100.0%

MTNB-89.8%

YTD Performance

ADTX-100.0%

MTNB-69.1%

% from 52W High

ADTX-100.0%

MTNB-90.1%

% from 52W Low

ADTXN/A

MTNB27.1%

Asset Turnover (TTM)

ADTX0.00x

MTNB0.09x

FCF Yield (TTM)

ADTX-186.2%

MTNB-16.3%

Earnings Yield (TTM)

ADTX-534.5%

MTNB-8.8%

Dividend Yield (TTM)

ADTXN/A

MTNBN/A

Rule of 40

ADTX-129,086.5

MTNB0.0

EV/GP/RG

ADTXN/A

MTNBN/A

Ticker research

View ADTX research View MTNB research

Metric	ADTX Aditxt Inc	MTNB Matinas BioPharma Holdings Inc
Market & Valuation
Market Cap	$10M	$39M
Enterprise Value	$13M	$39M
Price	$0.01	$2.87
P/E Ratio	N/A	N/A
P/S Ratio	693.04x	0.60x
EV/Sales	903.97x	0.43x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.53x	1.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.70x	-6.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$14K	$0
Revenue Growth (YoY)	-74.0%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	20.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-125503.5%	0.0%
Net Margin (TTM)	-370408.3%	0.0%
FCF Margin (TTM)	-129012.5%	N/A
Net Income (TTM)	$-53M	$-3M
FCF (TTM)	$-19M	$-6M
EPS (TTM)	-$2,640.53	$0.00
ROE (TTM)	-15077.0%	-13745.0%
ROA (TTM)	-27739.0%	-9202.0%
ROIC (TTM)	-11833.0%	-13717.0%
Financial Health
Cash	$269K	$761K
Debt	$3M	$6K
Net Cash/Debt	$-3M	$755K
Current Ratio (TTM)	0.06x	0.85x
Quick Ratio (TTM)	0.02x	0.60x
Debt/Equity (TTM)	0.33x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.31	2.20
52W Performance	-100.0%	-89.8%
YTD Performance	-100.0%	-69.1%
% from 52W High	-100.0%	-90.1%
% from 52W Low	N/A	27.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.09x
FCF Yield (TTM)	-186.2%	-16.3%
Earnings Yield (TTM)	-534.5%	-8.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-129,086.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ADTX research	View MTNB research